0
0
1/6/23 at 5:27am
Organization
CNBC
Author
Jenni Reid
36 words
0
Comments
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
You are the first to view
https://www.cnbc.com/2023/01/06/biontech-says-it-will-start-cancer-vaccine-trials-in-the-uk-from-september.html
Create an account
or login to join the discussion